Meet our experienced team

Our Leadership Team, Board of Directors, and Scientific Advisors collectively bring over two hundred years of drug development and execution experience to Attovia. We harness this power to bring treatments to patients where none exist and to create best-in-class options where current solutions fall short. Together, we envision a world where no patient is left behind.

Meet Our Experienced Team

Our Leadership Team, Board of Directors and Scientific Advisors collectively bring over two hundred years of drug development and execution experience to Attovia. We harness this power to bring treatments to patients where none exist and to create best-in-class options where current solutions fall short. Together, we envision a world where no patient is left behind.

Leadership Team

Leadership Team

Image of Tao Fu, Attovia CEO

Tao Fu, MBA, M.S.

Chief Executive Officer

Image of Steven Chan, Attovia CFO

Steven Chan

Chief Financial Officer

Hubert Chen, M.D., M.P.H.

Chief Medical Officer

Zaneta Odrowaz. CBO

Zaneta Odrowaz, Ph.D.

Chief Business Officer

Petter Veiby, CSO

Petter Veiby, Ph.D.

Chief Scientific Officer

Hangjun Zhan, CTO

Hangjun Zhan, Ph.D.

Chief Technology Officer

David Bellovin, Ph.D.

Vice President, Discovery and Translational Biology

Bora Han, Ph.D.

Vice President, Head of Preclinical Development

Veit Schmelmer, Ph.D.

Vice President, Project Management and Portfolio Strategy

Board of Directors

Board of Directors

Jamie Topper, M.D., Ph.D.
Chairman

Tao Fu, MBA, M.S.
Director

Mitchell Gold, M.D.
Director

Yuling Luo, Ph.D.
Director

Yuling Luo,
Ph.D.
Director

Rebecca Luse
Director

Aaron Royston, M.D., MBA
Director

Colin Walsh, Ph.D.
Director

Angie You, Ph.D.
Director

Clinical and Scientific Advisors

Clinical and Scientific Advisors

Richard Heyman

Richard Heyman, Ph.D.

Chairman of the Board
Oric Pharmaceuticals and RayzeBio

David King

David King, Ph.D.

CSO and Co-Founder
Lassen Therapeutics

Luisa_Salter-Cid

Luisa Salter-Cid, Ph.D.

CSO
Pioneering Medicines

Jonathan Silverberg

Jonathan Silverberg, M.D., PhD.

Director of Clinical Research
The George Washington University School of Medicine and Health Sciences